COVID: New Omicron subvariant ‘appears to have growth advantage’

The UK Health security agency says early assessment does not find difference in vaccine effectiveness between subtypes.

from Al Jazeera – Breaking News, World News and Video from Al Jazeera https://ift.tt/340psAv